ArticleAnalytical and bioanalytical chemistry2026
Standardizing NIR spectroscopy for PAT in phytopharmaceutical applications: multivariate detection and quantification limits of vitexin and isovitexin.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Near-infrared (NIR) spectroscopy, in combination with multivariate calibration, plays a central role in process analytical technology (PAT) for quantitative analysis. While detection and quantification limits (LOD/LOQ) are critical performance indicators, their estimation in multivariate models remains non-trivial-especially in complex systems such as phytopharmaceuticals. This study compares two multivariate LOD/LOQ estimation frameworks: the variance-leverage based mLOD/mLOQ (IUPAC-compliant, geometry-driven) and the net analyte signal (NAS)-based approach, which quantifies analyte-specific signals orthogonalized against the model background. Partial least squares regression (PLS-R) models were developed for vitexin and isovitexin in phytopharmaceutical samples of Passiflora incarnata. The study included four NIR spectrometers (benchtop and handheld) implementing various optical principles, as well as two sample conditions (milled, intact). LOD/LOQ estimates were systematically evaluated against the influence of latent variable structure, model complexity, and orthogonal signal correction (OSC), a spectral preprocessing technique that explicitly enhances the isolation of analyte-specific variance. The results demonstrate how mLOD and NAS-LOD respond to model geometry when applied to phytopharmaceutical matrices. Both frameworks explicitly depend on the latent structure constructed in the PLS-R model; however, NAS-LOD is highly sensitive to analyte signal alignment and dispersion across latent variables, while mLOD reflects variance-weighted geometric detectability. OSC pretreatment improved the analyte signal concentration in early latent variables and led to markedly reduced NAS-LOD values, while mLOD values showed substantial responsiveness to latent space compression in the models. The combined use of both frameworks, supported by latent space diagnostics (analyte variance per LV, projection of pure standards), provides a multi-layered evaluation of model transparency and internal structure. These findings demonstrate that multivariate LOD/LOQ estimation can reinforce PAT-oriented method development not only as a validation metric, but as a diagnostic tool that provides standardized measures for controlling the NIR analytical method.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.